Evidence map›Paper›PMID 31076504›Full record

Trial reportJournal of nuclear medicine : official publication, Society of Nuclear Medicine2019

Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic

Daniela Thorwarth, Stefan Welz, David Mönnich, Christina Pfannenberg, Konstantin Nikolaou, Matthias Reimold, Christian La Fougère, Gerald Reischl, Paul-Stefan Mauz, Frank Paulsen and 3 more

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 52 citations in OpenAlex.

  1. Hypoxia-Directed Treatment of Human Papillomavirus-Related Oropharyngeal Carcinoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Trial
  2. Review
  3. Article
  4. Review
  5. Use of Radiomics in Characterizing Tumor Hypoxia.International journal of molecular sciences · 2025
    Review
  6. Review
  7. Review
  8. Development ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  9. Observational
  10. Article
  11. Review
  12. Article
  13. Synthesis of [EJNMMI radiopharmacy and chemistry · 2023
    Article
  14. Review
  15. Review
  16. Value of PET imaging for radiation therapy.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2021
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Daniela ThorwarthSection for Biomedical Physics, Department of Radiation Oncology, University of Tübingen, Tübingen, Germany daniela.thorwarth@med.uni-tuebingen.de.
Stefan WelzDepartment of Radiation Oncology, University of Tübingen, Tübingen, Germany.
David MönnichSection for Biomedical Physics, Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
Christina PfannenbergDiagnostic and Interventional Radiology, Department of Radiology, University of Tübingen, Tübingen, Germany.
Konstantin NikolaouDiagnostic and Interventional Radiology, Department of Radiology, University of Tübingen, Tübingen, Germany.
Matthias ReimoldDepartment of Nuclear Medicine, University of Tübingen, Tübingen, Germany.
Christian La FougèreDepartment of Nuclear Medicine, University of Tübingen, Tübingen, Germany.
Gerald ReischlDepartment of Preclinical Imaging and Radiopharmacy, University of Tübingen, Tübingen, Germany.
Paul-Stefan MauzDepartment of Otorhinolaryngology, University of Tübingen, Tübingen, Germany.
Frank PaulsenDepartment of Radiation Oncology, University of Tübingen, Tübingen, Germany.
Markus AlberSection for Biomedical Physics, Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
Claus BelkaGerman Cancer Consortium, Tübingen, Germany, and German Cancer Research Center, Heidelberg, Germany.
Daniel ZipsGerman Cancer Consortium, Tübingen, Germany, and German Cancer Research Center, Heidelberg, Germany.
University of Tübingen · DEGerman Cancer Research Center · DEHeidelberg University · DELMU Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our purpose was to evaluate an imaging parameter-response relationship between the extent of tumor hypoxia quantified by dynamic

Indexed as

Positron Emission Tomography Computed TomographyAgedFemaleHead and Neck NeoplasmsHumansMaleMiddle AgedMisonidazoleProbabilityProspective StudiesfluoromisonidazoleMisonidazole18F-FMISO PET/CThead and neck cancerhypoxiaoutcome predictionradiotherapyTCP model

Identifiers

PMID31076504
PMCPMC6894382
OpenAlexW2944674272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.